Skip to content

Analysis of Markers Associated with Prognosis After Meningioma Surgery

Study on the Correlation between Clinical Prognosis and Risk Stratification Biomarkers after Meningioma Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120744
Enrollment
Unknown
Registered
2026-03-19
Start date
2026-03-20
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meningiomas

Interventions

Sponsors

Yuebei People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >=18 years, regardless of gender; 2.Underwent meningioma resection surgery and were pathologically diagnosed with meningioma; 3.Completed routine blood tests and biochemical metabolic markers within 24 hours before surgery (allowing for biomarker calculation); 4.Complete preoperative and postoperative imaging data; 5.Complete follow-up information and data;

Exclusion criteria

Exclusion criteria: 1. Patients who have received other interventional treatments (such as surgery or radiotherapy at other hospitals) before receiving treatment and whose treatment effects cannot be clearly defined; 2. Patients with severe systemic diseases or other malignant tumors that may significantly affect prognosis assessment; 3. Patients whose imaging and pathological data have too long an interval between them;

Design outcomes

Primary

MeasureTime frame
Postoperative functional outcomes;

Secondary

MeasureTime frame
Postoperative complications;

Countries

China

Contacts

Public ContactXiang Liu

Yuebei People’s Hospital

liuxiangxl72@163.com+86 751 691 3416

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026